Evidence map›Paper›PMID 37232132›Full record

ArticleAIDS care2023

Barriers and facilitators to PrEP use and HIV testing for subgroups of Latino sexual minority men.

Alyssa Lozano, Jahn Jaramillo, Guillermo Prado, Steven A Safren, Audrey Harkness

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alyssa LozanoDepartment of Public Health Sciences, University of Miami Miller School of Medicine, University of Miami, Miami, FL, USA.ORCID 0000-0003-2827-5463
Jahn JaramilloDepartment of Public Health Sciences, University of Miami Miller School of Medicine, University of Miami, Miami, FL, USA.
Guillermo PradoSchool of Nursing and Health Studies, University of Miami, Coral Gables, FL, USA.
Steven A SafrenDepartment of Psychology, University of Miami, Coral Gables, FL, USA.ORCID 0000-0002-0121-0806
Audrey HarknessSchool of Nursing and Health Studies, University of Miami, Coral Gables, FL, USA.ORCID 0000-0003-2290-9904
University of Miami · US

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Rana Chakraborty · 2007 to 2026
$33.8M
SET-Enhanced Aftercare for Mothers in Substance Abuse Recovery and Their ChildreP60MD002266 · NIMHD · UNIVERSITY OF MIAMI CORAL GABLES · PI PERAGALLO MONTANO, NILDA P · 2007 to 2016
$13.6M
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core & MHD-CEP30MH133399 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI Victoria Behar-Zusman · 2023 to 2026
$8.9M
Hispanic Men Building Respect Education and Safety/ Hombres Manteniendo Respeto, Educacion y Seguridad (HOMBRES DE FAMILIA)U54MD002266 · NIMHD · UNIVERSITY OF MIAMI CORAL GABLES · PI BEHAR-ZUSMAN, VICTORIA, DE LA ROSA, MARIO R · 2017 to 2022
$8.3M
University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)P30MH116867 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI SAFREN, STEVEN A · 2019 to 2023
$6.5M
Developing and Pilot Testing Peer Ambassador Stories for Increasing HIV-Prevention and Behavioral Health Treatment Uptake among Latino MSMK23MD015690 · NIMHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARKNESS, AUDREY · 2020 to 2025
$1.1M
NIAID NIH HHS P30 AI073961NIMHD NIH HHS K23 MD015690NIMHD NIH HHS P60 MD002266NIMHD NIH HHS U54 MD002266NIMH NIH HHS P30 MH116867NIMH NIH HHS P30 MH133399
6 · The paper itself

Abstract

Pre-exposure prophylaxis (PrEP) and HIV testing inadequately reach Latino sexual minority men (LSMM), fueling HIV disparities. This study identified determinants of LSMM's PrEP use and HIV testing and examined differences across subgroups (i.e., age and immigration history). First, we identified the most to least endorsed barriers and facilitators of PrEP use and HIV testing among LSMM (1) over vs. under 40 years old, and (2) across immigration histories (U.S. born, recent immigrant, established immigrant). Next, we examined differences in barrier/facilitator ratings across these age and immigration status groups. Key overall determinants were cost, knowledge, and perceived benefit/need. However, there was variation in determinants across age groups (i.e., cost, affordability, navigation support, and normalization) and immigration statuses (i.e., language, immigration concerns, and HIV knowledge). There were also differences across service types; mistrust and concerns was a barrier related to PrEP but not HIV testing. We found unique and common multilevel factors across prevention services and subgroups. Language, cost, and clinic/system issues are key barriers in accessing HIV prevention that should be considered when developing implementation strategies to enhance the reach of these services to LSMM.

Indexed as

Anti-HIV AgentsHealth Services AccessibilityHIV InfectionsHomosexuality, MalePre-Exposure ProphylaxisAdultAge FactorsEmigrants and ImmigrantsHispanic or LatinoHumansMaleMenSexual and Gender MinoritiesAnti-HIV AgentsageHIVimmigration statusLatinoPrEP

Identifiers

PMID37232132
PMCPMC10524698
OpenAlexW4378348783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.